YTEN
Income statement / Annual
Last year (2023), Yield10 Bioscience, Inc.'s total revenue was $60,000.00,
a decrease of 86.67% from the previous year.
In 2023, Yield10 Bioscience, Inc.'s net income was -$14.46 M.
See Yield10 Bioscience, Inc.’s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
Operating Revenue |
$60,000.00
|
$450,000.00
|
$614,000.00
|
$799,000.00
|
$806,000.00
|
$556,000.00
|
$944,000.00
|
$1.16 M
|
$2.59 M
|
$2.80 M
|
Cost of Revenue |
$290,000.00 |
$656,000.00 |
$578,000.00 |
$5.22 M |
$4.85 M |
$4.78 M |
$4.60 M |
$5.67 M |
$660,000.00 |
$1.48 M |
Gross Profit |
-$230,000.00 |
-$206,000.00 |
$36,000.00 |
-$4.42 M |
-$4.04 M |
-$4.23 M |
-$3.65 M |
-$4.51 M |
$1.93 M |
$1.32 M |
Gross Profit Ratio |
-3.83 |
-0.46 |
0.06 |
-5.53 |
-5.01 |
-7.6 |
-3.87 |
-3.89 |
0.75 |
0.47 |
Research and Development
Expenses |
$8.32 M
|
$7.75 M
|
$6.20 M
|
$5.36 M
|
$4.85 M
|
$4.78 M
|
$4.60 M
|
$5.67 M
|
$16.57 M
|
$17.34 M
|
General & Administrative
Expenses |
$6.15 M
|
$6.15 M
|
$6.11 M
|
$5.05 M
|
$4.55 M
|
$5.09 M
|
$5.63 M
|
$5.74 M
|
$9.11 M
|
$10.81 M
|
Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General &
Administrative Expenses |
$6.15 M
|
$6.15 M
|
$6.11 M
|
$5.05 M
|
$4.55 M
|
$5.09 M
|
$5.63 M
|
$5.74 M
|
$9.11 M
|
$10.81 M
|
Other Expenses |
$0.00 |
$41,000.00 |
-$3,000.00 |
$83,000.00 |
$21,000.00 |
$134,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Operating Expenses |
$14.48 M |
$13.90 M |
$12.31 M |
$10.41 M |
$9.40 M |
$9.88 M |
$10.23 M |
$11.41 M |
$25.68 M |
$28.15 M |
Cost And Expenses |
$14.48 M |
$13.90 M |
$12.31 M |
$10.41 M |
$9.40 M |
$9.88 M |
$10.23 M |
$11.41 M |
$26.34 M |
$29.63 M |
Interest Income |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$96,000.00 |
$158,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Interest Expense |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$13.02 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Depreciation &
Amortization |
$290,000.00
|
$656,000.00
|
$578,000.00
|
$611,000.00
|
$1.83 M
|
$784,000.00
|
$206,000.00
|
$177,000.00
|
$265,000.00
|
$507,000.00
|
EBITDA |
-$14.13 M
|
-$13.19 M
|
-$11.47 M
|
-$9.43 M
|
-$8.39 M
|
-$9.12 M
|
-$9.08 M
|
-$10.07 M
|
-$12.35 M
|
-$26.32 M
|
EBITDA Ratio |
-235.45 |
-29.31 |
-19.82 |
-11.02 |
-6.1 |
-16.41 |
-9.5 |
-8.36 |
-9.07 |
-9.42 |
Operating Income Ratio
|
-240.28
|
-29.89
|
-19.04
|
-12.03
|
-10.67
|
-16.76
|
-9.83
|
-8.84
|
-9.15
|
-9.58
|
Total Other
Income/Expenses Net |
-$38,000.00
|
$41,000.00
|
$697,000.00
|
-$541,000.00
|
-$4.61 M
|
$134,000.00
|
-$113,000.00
|
-$38,000.00
|
$29,000.00
|
$61,000.00
|
Income Before Tax |
-$14.46 M |
-$13.41 M |
-$11.00 M |
-$10.15 M |
-$13.21 M |
-$9.19 M |
-$9.40 M |
-$10.29 M |
-$23.68 M |
-$26.77 M |
Income Before Tax Ratio
|
-240.92
|
-29.8
|
-17.91
|
-12.7
|
-16.39
|
-16.52
|
-9.95
|
-8.87
|
-9.13
|
-9.56
|
Income Tax Expense |
$0.00 |
$156,000.00 |
$36,000.00 |
$56,000.00 |
-$254,000.00 |
$104,000.00 |
$113,000.00 |
-$1.10 M |
-$62,000.00 |
$2.71 M |
Net Income |
-$14.46 M |
-$13.57 M |
-$11.03 M |
-$10.21 M |
-$12.96 M |
-$9.19 M |
-$9.40 M |
-$7.60 M |
-$23.68 M |
-$29.53 M |
Net Income Ratio |
-240.92 |
-30.15 |
-17.97 |
-12.77 |
-16.07 |
-16.52 |
-9.95 |
-6.56 |
-9.13 |
-10.55 |
EPS |
-43.66 |
-66.25 |
-55.95 |
-103.21 |
-851.98 |
-887.78 |
-2771.06 |
-2651.74 |
-9184.37 |
-27966.3 |
EPS Diluted |
-43.66 |
-66.25 |
-55.95 |
-103.21 |
-851.98 |
-887.78 |
-2771.06 |
-2651.74 |
-9184.37 |
-27966.3 |
Weighted Average Shares
Out |
$331,095.00
|
$204,774.00
|
$197,160.00
|
$98,886.00
|
$15,207.00
|
$10,346.00
|
$3,390.76
|
$2,867.55
|
$2,578.40
|
$1,056.06
|
Weighted Average Shares
Out Diluted |
$331,095.00
|
$204,774.00
|
$197,160.00
|
$98,886.00
|
$15,207.00
|
$10,346.00
|
$3,390.76
|
$2,867.55
|
$2,578.40
|
$1,056.06
|
Link |
|
|
|
|
|
|
|
|
|
|